Literature DB >> 20835624

HIV-1 RNA detection in the amniotic fluid of HIV-infected pregnant women.

Ana Christina Lobato1, Regina Amélia Aguiar, Agdemir Waléria Aleixo, Beatriz Amélia Andrade, Ines Katherina Cavallo, Fabiana Maria Kakehasi, Jorge Andrade Pinto, Victor Hugo Melo.   

Abstract

This study is aimed at evaluating the potential to detect human immunodeficiency virus (HIV) in amniotic fluid (AF) collected at delivery from 40 HIV-positive pregnant women. Thirty patients had a plasma viral load (VL) below 1,000 copies/mL at delivery. VL was positive in three AF samples. No significant association was found between the HIV-1 RNA in AF and the maternal plasma samples. There was no HIV vertical transmission detected.

Entities:  

Mesh:

Year:  2010        PMID: 20835624     DOI: 10.1590/s0074-02762010000500021

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  4 in total

1.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

Review 2.  The role of cell-associated virus in mother-to-child HIV transmission.

Authors:  Caitlin Milligan; Julie Overbaugh
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

3.  Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?

Authors:  Nisha Andany; Michelle Letchumanan; Lise Bondy; Kellie Murphy; Mona R Loutfy
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 4.  Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.

Authors:  Omayma Amin; Jenna Powers; Katherine M Bricker; Ann Chahroudi
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.